96-8785. Advisory Committee on the Medical Uses of Isotopes; Renewal Notice
[Federal Register Volume 61, Number 69 (Tuesday, April 9, 1996)]
[Notices]
[Pages 15838-15839]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-8785]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes; Renewal
Notice
Agency: U.S. Nuclear Regulatory Commission.
Action: This notice is to announce the renewal of the Advisory
Committee on the Medical Uses of Isotopes for a period of 2 years.
-----------------------------------------------------------------------
Supplementary Information: The Nuclear Regulatory Commission (NRC) has
determined that the renewal of the charter for the Advisory Committee
on the Medical Uses of Isotopes (ACMUI) for the 2 year period beginning
on April 4, 1996, is in the public interest, in connection with duties
imposed on the Commission by law. This action is being taken in
accordance with the Federal Advisory Committee Act, after consultation
with the Committee Management Secretariat, General Services
Administration.
The purpose of the (ACMUI) is to provide advice to the NRC on
policy and technical issues that arise in regulating the medical use of
byproduct material for diagnosis and therapy. Responsibilities include
providing guidance and comments on current and proposed NRC regulations
and regulatory guidance concerning medical use; evaluating certain non-
routine uses of byproduct material for medical use; and evaluating
training and experience of proposed authorized users. The members are
involved in preliminary discussions of major issues in determining the
need for changes in NRC policy and regulation to ensure the continued
safe use of byproduct material. Each member provides technical
assistance in his/her specific area(s) of expertise, particularly with
respect to emerging technologies. Members also provide guidance as to
NRC's role in relation to the responsibilities of other Federal
agencies, as well as to professional organizations and boards.
Members of this Committee have demonstrated professional
qualifications and expertise in both scientific and non-scientific
disciplines, including nuclear medicine; nuclear cardiology; radiation
therapy; medical physics; radiopharmacy; State medical regulation;
patient's rights and care; health care administration; medical
[[Page 15839]]
research; medical dosimetry, and Food and Drug Administration
regulation.
For further information please contact: Torre Taylor, Office of Nuclear
Material Safety and Safeguards, U.S. Nuclear Regulatory Commission, MS
T8F5, Washington, DC 20555; Telephone (301) 415-7900.
Dated: April 4, 1996.
Andrew L. Bates,
Federal Advisory Committee Management Officer.
[FR Doc. 96-8785 Filed 4-8-96; 8:45 am]
BILLING CODE 7590-01-P
Document Information
- Published:
- 04/09/1996
- Department:
- Nuclear Regulatory Commission
- Entry Type:
- Notice
- Action:
- This notice is to announce the renewal of the Advisory Committee on the Medical Uses of Isotopes for a period of 2 years.
- Document Number:
- 96-8785
- Pages:
- 15838-15839 (2 pages)
- PDF File:
-
96-8785.pdf